CLINEXEL is scientific process organization providing scientific support and services to pharma industry and research organizations. WE provide services to pharma, biotech and medical device companies in pharmacovigilance commitments, medical information practices and clinical research for registration and post marketing commitments.
CLINEXEL has expertise to support the pharma industry in pharmacovigilance, clinical research, medical information and medical writing. WE are a team of committed and talented professional include pharmaceutical physicians and pharmacists, clinical research professionals, expert clinicians and medical writers.
CLINEXEL team is motivated and committed to provide state-of-the art customized service to support post approval pharmacovigilance, clinical commitments and medical information; and preapproval drug safety and clinical research requirements.
Dr Deepa Arora is a Physician with more than 20 years of experience in pharma industry and academia. She has led different functions including drug safety for products under clinical development as well as post approval for regulated markets, clinical development of biosimilars of US FDA and EMEA, clinical operations, medical information, post authorization studies and registries. See More
Penelope Przekop, MSQA, RQAP-GCP is a Quality Systems Engineer and GXP Quality Assurance/ Systems & Compliance Consultant who brings more than 25 years of industry experience to CLINEXEL. She is the CEO of PDC Pharma Strategy (A division of PDC, LLC), a company that develops and executes GCP and PV risk-based strategies that support comprehensive global regulatory compliance. See More
Ms Wendy Huisman
(Founder of Vigifit)
Sr Pharmacovigilance Expert/ EU-QPPV Ms Wendy Huisman brings huge experience and expertise to Clinexel. She’s a highlyrespected Pharmacovigilance expert with extensive experience. She was EU-QPPV for Teva Pharmaceuticals Europe for 12 years, responsible for generic, innovative and biologic portfolio of Teva. She’s Advisory Board Member of the Pharmacovigilance . See More